DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Sheraton Philadelphia Downtown Hotel

2024年10月24日 (木) 午前 7:30 - 2024年10月25日 (金) 午後 4:10

201 North 17th Street, Philadelphia, PA 19103

Real-World Evidence Conference

Translating Insights into Real-World Value

Register Today!

DAYS

HOURS

MINUTES

SECONDS

Session 5: Health Equity in Drug Development: Leveraging RWD to Inform and Improve Diversity

Session Chair(s)

Brittany Avin McKelvey, PhD

Brittany Avin McKelvey, PhD

Director, Regualtory Affairs

Friends of Cancer Research, United States

Historically, clinical trials lack inclusion and representativeness that may hinder the generalizability of results to the intended patient population and contribute to existing health inequities. Real-world data (RWD) can provide context and insights both to set appropriate goals for diversity in clinical research, as well as provide additional information on diverse patient populations. This session will discuss the types of data and evaluation of appropriate data sources to define diversity, inclusion, and representativeness, with a special focus on Social Determinants of Health and health equity, and how to incorporate RWD to enhance drug development for a more comprehensive view of the population of interest.

Learning Objective :
  • Identify what factors should be captured in RWD sources to define representativeness, diversity, and inclusion
  • Describe how to leverage RWD and mitigate biases to generate insights on diversity and representativeness for a variety of research objectives in drug development
  • Demonstrate example applications of RWD to build diverse and inclusive study populations across drug development strategies

Speaker(s)

Brittany Avin McKelvey, PhD

Implementing Diversity Action Plans: Current Experience and Future Opportunities

Brittany Avin McKelvey, PhD

Friends of Cancer Research, United States

Director, Regualtory Affairs

Melinda  Baker, PhD

Representative of What? Pragmatic Strategies to Improve Diversity and Inclusion When the Research Questions Demand it

Melinda Baker, PhD

Mission Health Labs, Inc. (dba PicnicHealth), United States

Director of Dataset Strategy & Commercialization

P. Karina  D'Angelo, PhD

Discovering Patient Barriers in Real-World Data to Inform Diversity Strategies

P. Karina D'Angelo, PhD

Parexel, United States

Director, Scientific Data Strategy

Representative Invited

Lessons Learned: Health Equity in Medicare Claims Data Research

Representative Invited

FDA, United States

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。